Delivery Order SPE2DB20D2104-SPE2DB25FNBAT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,642.00 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $11,722.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $13,532.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. The award, issued on December 15, 2025, is a non-set-aside, competitively awarded contract with an ultimate completion date of December 16, 2025. This delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,554.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $20,050.94 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is classified as firm fixed price with no set-aside designation and is scheduled for ultimate completion by November 3, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $8,321.43 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a completion date of June 26, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $2,673.56 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,736.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with a completion date of December 10, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $5,864.87 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric/oncology pharmaceutical supply within the federal medical procurement system. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at...
- The Defense Logistics Agency awarded a $2,499.65 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price delivery order with completion scheduled for December 10, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBATDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $22,755.05 to supply Ondansetron ODT 4 mg tablets (30-count packaging), with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order supporting federal pharmaceutical procurement needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 9/19/25 |